Wed, Dec 17, 2014, 7:45 PM EST - U.S. Markets closed


% | $
Quotes you view appear here for quick access.

Becton, Dickinson and Company Message Board

  • bluecheese4u bluecheese4u Aug 2, 2012 4:29 PM Flag



    Reported results reflect reclassification of Discovery Labware unit as discontinued operations, excluding Advanced Bioprocessing.

    Third-quarter earnings per share of $1.59 include $1.52 from continuing operations and $0.07 from discontinued operations relating to the Discovery Labware unit.
    Franklin Lakes, NJ (August 2, 2012) – BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, today reported quarterly revenues of $1.981 billion for the third fiscal quarter ended June 30, 2012, representing an increase of 1.5 percent from the prior-year period, or 4.9 percent on a foreign currency-neutral basis.
    “We are very pleased with our third quarter results,” said Vincent A. Forlenza, Chairman of the Board, Chief Executive Officer and President. “As we anticipated, our revenue and earnings growth improved this quarter, demonstrating that our strategy implementation is on track and in line with our previously communicated expectations.”
    Update on Agreement to Sell Discovery Labware Unit, Excluding Advanced Bioprocessing
    In April 2012, the Company signed a definitive agreement to sell its BD Biosciences - Discovery Labware unit, excluding its Advanced Bioprocessing platform. The transaction is expected to be completed by the end of calendar year 2012, subject to the satisfaction of customary closing conditions, including consultations and regulatory approvals. The results of operations associated with this disposal group have been reclassified as discontinued operations for all quarters and years referred to in this release.
    As illustrated on page 3 of the attached financial tables, diluted earnings per share for the third quarter of $1.59 less the $0.07 from discontinued operations resulted in earnings per share from continuing operations of $1.52.

    BD Third Quarter Results Fiscal Year 2012 Financial Presentation »

136.80+2.76(+2.06%)Dec 17 4:02 PMEST

Trending Tickers

Trending Tickers features significant U.S. stocks showing the most dramatic increase in user interest in Yahoo Finance in the previous hour over historic norms. The list is limited to those equities which trade at least 100,000 shares on an average day and have a market cap of more than $300 million.
Oracle Corporation
NYSEWed, Dec 17, 2014 4:02 PM EST
Volcano Corporation
NasdaqGSWed, Dec 17, 2014 4:00 PM EST
Auspex Pharmaceuticals, Inc.
NasdaqGMWed, Dec 17, 2014 4:00 PM EST